When should cervical cancer screening be stopped in women, considering age, prior screening results, and hysterectomy status?

When to Stop Cervical Cancer Screening

Stop cervical cancer screening at age 65 years if the patient has had adequate prior screening: either 3 consecutive negative cytology results OR 2 consecutive negative co-tests (cytology plus HPV) within the past 10 years, with the most recent test performed within 5 years 1, 2, 3.

Key Criteria for Stopping Screening

Age and Screening History Requirements

The decision to stop screening requires meeting ALL of the following:

• Age ≥65 years (some guidelines extend to age 70)
• Adequate prior screening documented:
  • 3 consecutive negative Pap tests over 10 years, OR
  • 2 consecutive negative co-tests (Pap + HPV) over 10 years
  • Most recent test must be within the past 5 years 1, 2
• No history of CIN2+ (moderate or severe dysplasia) in the past 25 years 2
• No history of cervical cancer ever
• Not immunocompromised or HIV-positive

Hysterectomy Status

Stop screening immediately at any age if the patient has had a total hysterectomy with removal of the cervix AND no history of CIN2+ in the past 25 years or cervical cancer ever 1, 3. This applies regardless of age or prior screening history.

Critical Pitfalls to Avoid

The Documentation Problem

Most women do NOT meet exit criteria when examined carefully - studies show that 65-67% of women aged 64-66 lack sufficient documentation to confirm adequate prior screening 4. This is a major real-world challenge because:

• Insurance claims may not capture all screening history
• Patients change providers and records are lost
• Many women discontinue screening without meeting criteria

Do not assume adequate screening without documentation - actively verify the screening history before stopping.

High-Risk Populations Who Should Continue Screening

Continue screening beyond age 65 in:

• History of CIN2, CIN3, or cervical cancer - continue for 25 years after treatment, even if this extends past age 65 2
• Inadequate prior screening - continue until criteria are met, regardless of age 1, 2
• Immunocompromised patients (HIV, transplant recipients, chronic steroids)
• In utero DES exposure

The Post-65 Cancer Risk Reality

While the risk is low in adequately screened women, approximately 20% of new cervical cancers occur in women ≥65 years, and 25% of cervical cancer deaths come from diagnoses after age 65 2. The vast majority of these cases occur in underscreened or unscreened women, emphasizing why meeting exit criteria is crucial.

Recent modeling data shows cumulative cancer risk by age 85 ranges from 0.026-0.081% in women who properly met exit criteria 5, which is acceptably low but not zero.

Strength of Evidence

The 2020 American Cancer Society guidelines 2 represent the most recent comprehensive update and align closely with the 2018 USPSTF recommendations 3 and 2015 ACP guidelines 1. The evidence consistently shows that negative co-testing (Pap + HPV) provides stronger protection than cytology alone 2, which is why only 2 negative co-tests are required versus 3 negative Pap tests.

The protective effect of adequate screening is substantial - studies uniformly demonstrate that cervical cancer after age 65 is uncommon in properly screened populations 2.

Practical Algorithm

1. Verify age ≥65 years
2. Review complete screening history for past 10 years:
   • Can you document 2 negative co-tests OR 3 negative Pap tests?
   • Was the most recent test within 5 years?
3. Check for disqualifying history:
   • Any CIN2+ in past 25 years? → Continue screening
   • Any cervical cancer ever? → Continue screening
   • HIV or immunocompromised? → Continue screening
4. Confirm cervix present:
   • Total hysterectomy with cervix removed + no CIN2+/cancer history? → Stop screening at any age
5. If all criteria met → Stop screening
6. If criteria NOT met → Continue screening until they are, regardless of age